Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1269 (LINC01269)
- Target
- LINC01269
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1269 (LINC01269) is a non-coding RNA gene that does not encode a protein but is believed to regulate gene expression and cellular function through multiple RNA-based mechanisms. It is classified as a long intergenic non-coding RNA, a subclass of lncRNAs transcribed from genomic regions between annotated protein-coding genes, and may function in chromatin remodeling, transcriptional regulation, and as a molecular scaffold for protein complexes. LINC01269 and its aliases have been associated with cancer biology, particularly in head and neck squamous cell carcinoma, but its detailed molecular pathways and disease mechanisms remain under-explored.
- Other names
- HNSCAT1PARLncRNA-1lncRNA-RP6-65G23.1Platelet activation-related lncRNA 1Head and neck squamous carcinoma associated transcript 1
02
Mechanism of action
No mechanism of direct drug action exists; as a non-coding RNA, its effects are believed to be via modulation of endogenous gene/protein expression.
03
Biological functions
Regulation of gene expression (including at chromatin, transcriptional, and post-transcriptional levels)Potential involvement as a molecular scaffold for proteinsModulation of splicing or nuclear compartmentalization
04
Disease associations
Cancer (notably head and neck squamous cell carcinoma, based on its alias and emerging reports)Other roles possible but not yet firmly established in literature
05
Safety considerations
None specifically documented for LINC01269 itself. However, lncRNAs as a class present general challenges in therapeutic targeting, including specificity, delivery, and potential off-target genetic effects.
06
Biomarkers
Possible use as a cancer biomarker, e.g., in head and neck squamous cell carcinoma, implied by its alternate names and some initial reports
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1269 (LINC01269).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1269 (LINC01269).